# Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening

> **NCT04102722** · NA · UNKNOWN · sponsor: **Transonic Imaging, Inc.** · enrollment: 1333 (estimated)

## Conditions studied

- Breast Cancer Screening

## Interventions

- **DEVICE:** MUST device

## Key facts

- **NCT ID:** NCT04102722
- **Lead sponsor:** Transonic Imaging, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-14
- **Primary completion:** 2020-11
- **Final completion:** 2021-11
- **Target enrollment:** 1333 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102722, "Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04102722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*